A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - academic.oup.com
Abstract Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
[PDF][PDF] A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - core.ac.uk
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
[PDF][PDF] A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - academic.oup.com
Abstract Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.
M Vaduganathan, PS Jhund… - European Heart …, 2020 - search.ebscohost.com
Abstract Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
against active controls given renin–angiotensin system inhibitors (RASi) are ethically …
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Aims</jats: title>< jats: p> The
PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active controls …
PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active controls …
A PUTATIVE PLACEBO ANALYSIS OF THE EFFECTS OF SACUBITRIL/VALSARTAN IN HEART FAILURE ACROSS THE FULL RANGE OF EJECTION FRACTION
M Vaduganathan, B Claggett, M Packer… - Journal of the American …, 2020 - jacc.org
Background The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan (S/V)
against active controls given renin-angiotensin-system inhibitors (RASi) are ethically …
against active controls given renin-angiotensin-system inhibitors (RASi) are ethically …
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction.
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - europepmc.org
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active
controls given renin-angiotensin system inhibitors (RASi) are ethically mandated in heart …
controls given renin-angiotensin system inhibitors (RASi) are ethically mandated in heart …
[PDF][PDF] A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund… - European Heart …, 2020 - pdfs.semanticscholar.org
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
[HTML][HTML] A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund, BL Claggett… - European Heart …, 2020 - ncbi.nlm.nih.gov
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
controls given renin–angiotensin system inhibitors (RASi) are ethically mandated in heart …
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
M Vaduganathan, PS Jhund… - European heart …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims The PARADIGM-HF and PARAGON-HF trials tested sacubitril/valsartan against active
controls given renin-angiotensin system inhibitors (RASi) are ethically mandated in heart …
controls given renin-angiotensin system inhibitors (RASi) are ethically mandated in heart …